Indefinite Delivery Contract 36C25926D0018

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. headquartered in Dublin, Ohio, was awarded a single-award Indefinite Delivery Contract valued at $2.66 million by Veterans Integrated Service Network 19 (a civilian agency within the Department of Veterans Affairs) on February 1, 2026, with an ultimate completion date of January 31, 2031. The contract, issued on an unrestricted basis with no set-aside designation and structured as a firm fixed-price engagement, procures radiopharmaceutical products and nuclear medicine supplies essential for diagnostic imaging and therapeutic oncology applications across Veterans Affairs medical centers. The scope encompasses a comprehensive portfolio of radiopharmaceutical products including Technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose (FDG), gallium-67, as well as specialized therapeutic radiopharmaceuticals such as Xofigo (radium-223 dichloride) for prostate cancer treatment, Lymphoseek for diagnostic imaging, and DETECTNET, with performance conducted from the contractor's primary facility in Dublin, Ohio. The original solicitation RFP #36C25926Q0144, posted January 8, 2026, with proposals due January 20, 2026, sought radiopharmaceutical products for the Rocky Mountain Regional Veterans Affairs Medical Center in Aurora, Colorado, under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), structured as a five-year Indefinite Delivery Indefinite Quantity contract with base year and four option years.

A task order issued under this Indefinite Delivery Contract on February 1, 2026, valued at $511,494.50, established initial delivery obligations through January 31, 2027, representing the first call against the contractor's established supply relationship with Veterans Integrated Service Network 19. Cardinal Health 414 maintains the regulatory certifications and operational capabilities necessary to fulfill this mission, including Nuclear Regulatory Commission licensing, Food and Drug Administration approval for radiopharmaceutical manufacturing and distribution, and Department of Transportation compliance for radioactive materials transport. The contractor's specialized expertise in managing radiopharmaceuticals with stringent time-sensitivity requirements—often necessitating one to one-and-a-half hour delivery turnaround times due to radioactive isotope half-lives—positions it as a critical supplier supporting nuclear medicine, diagnostic imaging services, and oncology treatment capabilities across the Department of Veterans Affairs' nationwide healthcare infrastructure.